Research Article
Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
Table 1
Clinicopathological features for the examined patients.
| | Characteristic | Group 1 | Group 2 |
value | | |
| | Age | | | | | <50 | 42 (42%) | 43 (36%) | >0,05 | | 50–69 years | 48 (48%) | 70 (59%) | | ≥70 years | 9 (42%) | 6 (5%) | | Menopausal status | | | | | Premenopausal | 67 (68%) | 69 (58%) | >0,05 | | Postmenopausal | 32 (32%) | 74 (36%) | | Tumor size | | | | | ≥2 cm | 73 (74%) | 35 (29%) | <0,05 | | 2,1–5 cm | 26 (26%) | 84 (71%) | | Tumor histological grade | | | | | High (G1) | 14 (14%) | 7 (6%) | >0,05 | | Middle (G2) | 73 (74%) | 98 (82%) | | Low (G3) | 10 (10%) | 11 (9%) | | Undifferentiated (G4) | 2 (2%) | 3 (3%) | | Regional lymph nodes involved | | | | | No | 61 (62%) | 69 (58%) | >0,05 | | Yes | 38 (38%) | 50 (42%) | | ER presence | | | | | Negative | 35 (35%) | 46 (39%) | >0,05 | | Positive | 64 (65%) | 73 (61%) | | PR presence | | | | | Negative | 37 (37%) | 51 (43%) | >0,05 | | Positive | 62 (63%) | 68 (57%) | | Her2/neu presence | | | | | Negative | 71 (72%) | 99 (83%) | >0,05 | | Positive | 28 (28%) | 20 (17%) | | Breast cancer subtypes | | | | | Luminal A | 47 (48%) | 73 (61%) | <0,05 | | Luminal B | 17 (17%) | 12 (10%) | >0,05 | | Her2-positive | 11 (11%) | 8 (7%) | | Triple negative | 24 (24%) | 26 (22%) |
|
|
